S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.02 (-2.95%)
AAPL   122.04 (-2.46%)
MSFT   227.39 (-2.77%)
FB   255.41 (-1.39%)
GOOGL   2,014.74 (-2.41%)
TSLA   656.90 (-4.30%)
AMZN   3,011.00 (-2.70%)
NVDA   513.25 (-4.29%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.44 (+3.54%)
MU   89.25 (-2.02%)
NIO   41.53 (-4.07%)
AMD   80.85 (-3.90%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   519.52 (-5.17%)
PFE   34.39 (+2.63%)
Log in
CVE:COT

Cotinga Pharmaceuticals Inc. (COT.V) News Headlines

C$0.04
-0.03 (-41.67 %)
(As of 10/14/2020)
Add
Compare
Today's Range
C$0.04
Now: C$0.04
C$0.04
50-Day Range
C$0.04
MA: C$0.03
C$0.04
52-Week Range
C$0.02
Now: C$0.04
C$0.12
Volume1,000 shs
Average Volume20,281 shs
Market CapitalizationC$769,510.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cotinga Pharmaceuticals Inc. (COT.V) (CVE COT) News Headlines Today

Source:
SourceHeadline
Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical IndustryFrost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry
finance.yahoo.com - June 9 at 12:51 PM
COTQF Cotinga Pharmaceuticals Inc - Ordinary SharesCOTQF Cotinga Pharmaceuticals Inc - Ordinary Shares
www.nasdaq.com - May 10 at 10:17 PM
How Does Investing In Cotinga Pharmaceuticals Inc. (CVE:COT) Impact The Volatility Of Your Portfolio?How Does Investing In Cotinga Pharmaceuticals Inc. (CVE:COT) Impact The Volatility Of Your Portfolio?
finance.yahoo.com - May 5 at 6:16 PM
Cotinga Pharmaceuticals Reports Fiscal 2019 First Quarter Financial and Operating ResultsCotinga Pharmaceuticals Reports Fiscal 2019 First Quarter Financial and Operating Results
www.bloomberg.com - April 26 at 7:07 PM
Cotinga Pharmaceuticals Inc. (COT.V)Cotinga Pharmaceuticals Inc. (COT.V)
finance.yahoo.com - March 29 at 11:44 PM
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid TumorsCotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors
www.nasdaq.com - July 19 at 12:46 PM
Cotinga Pharmacueticals Announces Closing of Second Tranche of Unit OfferingCotinga Pharmacueticals Announces Closing of Second Tranche of Unit Offering
finance.yahoo.com - June 5 at 10:47 AM
Cotinga Pharmacueticals Announces Closing of Unit OfferingCotinga Pharmacueticals Announces Closing of Unit Offering
www.nasdaq.com - May 23 at 10:49 AM
Cotinga Pharmaceuticals Releases Early Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid TumorsCotinga Pharmaceuticals Releases Early Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors
www.globenewswire.com - May 8 at 4:52 PM
Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit OfferingCotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering
www.globenewswire.com - March 19 at 11:24 AM
Cotinga Pharmaceuticals Enrolls Two Patients for Combination Therapy in Phase 1b/2a Trial of COTI-2Cotinga Pharmaceuticals Enrolls Two Patients for Combination Therapy in Phase 1b/2a Trial of COTI-2
globenewswire.com - January 8 at 4:35 PM
Cotinga Pharmaceuticals Reports Fiscal 2019 Second Quarter Financial and Operating ResultsCotinga Pharmaceuticals Reports Fiscal 2019 Second Quarter Financial and Operating Results
globenewswire.com - January 3 at 4:02 PM
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.